← Back to search

Xenon Pharmaceuticals Inc

XENE · NASDAQ

Pharmaceutical Preparation Manufacturing

Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

ESG Scores

Overall ESG
6.8
Environmental
6.4
Social
3.9
Governance
6.5

Gender Diversity

Female Directors0.25%
Female Executives0.23529411764705882%
CEO GenderMale